{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:57:26Z","timestamp":1775847446020,"version":"3.50.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1003,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007602","name":"NIHR Programme Grants for Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) is a global health burden and new strategies to achieve timely diagnosis and early intervention are urgently needed. Natriuretic peptide (NP) testing can be used to screen for left ventricular systolic dysfunction (LVSD), but evidence on test performance is mixed, and international HF guidelines differ in their recommendations. Our aim was to summarize the evidence on diagnostic accuracy of NP screening for LVSD in general and high-risk community populations and estimate optimal screening thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched relevant databases up to August 2020 for studies with a screened community population of over 100 adults reporting NP performance to diagnose LVSD. Study inclusion, quality assessment, and data extraction were conducted independently and in duplicate. Diagnostic test meta-analysis used hierarchical summary receiver operating characteristic curves to obtain estimates of pooled accuracy to detect LVSD, with optimal thresholds obtained to maximize the sum of sensitivity and specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four studies were identified, involving 26\u2009565 participants: eight studies in high-risk populations (at least one cardiovascular risk factor), 12 studies in general populations, and four in both high-risk and general populations combined. For detecting LVSD in screened high-risk populations with N-terminal prohormone brain natriuretic peptide (NT-proBNP), the pooled sensitivity was 0.87 [95% confidence interval (CI) 0.73\u20130.94] and specificity 0.84 (95% CI 0.55\u20130.96); for BNP, sensitivity was 0.75 (95% CI 0.65\u20130.83) and specificity 0.78 (95% CI 0.72\u20130.84). Heterogeneity between studies was high with variations in positivity threshold. Due to a paucity of high-risk studies that assessed NP performance at multiple thresholds, it was not possible to calculate optimal thresholds for LVSD screening in high-risk populations alone. To provide an indication of where the positivity threshold might lie, the pooled accuracy for LVSD screening in high-risk and general community populations were combined and gave an optimal cut-off of 311 pg\/mL [sensitivity 0.74 (95% CI 0.53\u20130.88), specificity 0.85 (95% CI 0.68\u20130.93)] for NT-proBNP and 49 pg\/mL [sensitivity 0.68 (95% CI 0.45\u20130.85), specificity 0.81 (0.67\u20130.90)] for BNP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that in high-risk community populations NP screening may accurately detect LVSD, potentially providing an important opportunity for diagnosis and early intervention. Our study highlights an urgent need for further prospective studies, as well as an individual participant data meta-analysis, to more precisely evaluate diagnostic accuracy and identify optimal screening thresholds in specifically defined community-based populations to inform future guideline recommendations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14314","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T01:28:41Z","timestamp":1676338121000},"page":"1643-1655","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostic Accuracy of Natriuretic Peptide Screening for Left Ventricular Systolic Dysfunction in the Community: Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-9661","authenticated-orcid":false,"given":"Clare R.","family":"Goyder","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea K.","family":"Roalfe","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy S.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Plumptre","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"James","sequence":"additional","affiliation":[{"name":"Clinical Medical School, University of Oxford, Level 3, John Radcliffe Hospital , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fanshawe","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F D Richard","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"2026012114095824100_ehf214314-bib-0001","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2026012114095824100_ehf214314-bib-0002","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0003","volume-title":"Chronic heart failure in adults: diagnosis and management (NICE guideline NG106)","author":"National Institute for Health and Care Excellence","year":"2018"},{"key":"2026012114095824100_ehf214314-bib-0004","first-page":"3599","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"42","author":"ESC Scientific Document Group","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114095824100_ehf214314-bib-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2016-013648","article-title":"From breathless to failure: symptom onset and diagnostic meaning in patients with heart failure-a qualitative study","volume":"7","author":"Taylor","year":"2017","journal-title":"BMJ Open"},{"key":"2026012114095824100_ehf214314-bib-0006","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/heartjnl-2017-312183","article-title":"Routes to diagnosis of heart failure: observational study using linked data in England","volume":"104","author":"Bottle","year":"2018","journal-title":"Heart"},{"key":"2026012114095824100_ehf214314-bib-0007","first-page":"1","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"2026012114095824100_ehf214314-bib-0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jchf.2015.12.007","article-title":"Asymptomatic left ventricular dysfunction: to screen or not to screen?","volume":"4","author":"Roger","year":"2016","journal-title":"JACC Hear Fail"},{"key":"2026012114095824100_ehf214314-bib-0009","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jchf.2015.09.015","article-title":"Assessing the risk of progression from asymptomatic left ventricular dysfunction to overt heart failure: a systematic overview and meta-analysis","volume":"4","author":"Echouffo-Tcheugui","year":"2016","journal-title":"JACC Hear Fail"},{"key":"2026012114095824100_ehf214314-bib-0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9149(99)80748-6","article-title":"Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction","volume":"75","author":"Benedict","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0011","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.105.600437","article-title":"Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction","volume":"113","author":"Goldberg","year":"2006","journal-title":"Circulation"},{"key":"2026012114095824100_ehf214314-bib-0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bmjebm-2019-111208","article-title":"Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis","volume":"25","author":"McLellan","year":"2020","journal-title":"BMJ Evidence-Based Med"},{"key":"2026012114095824100_ehf214314-bib-0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Gallagher","year":"2013","journal-title":"JAMA - J Am Med Assoc"},{"key":"2026012114095824100_ehf214314-bib-0014","first-page":"e137","volume-title":"ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer","author":"Yancy","year":"2017"},{"key":"2026012114095824100_ehf214314-bib-0015","first-page":"1342","article-title":"2017 comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0016","first-page":"1","article-title":"Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care","volume":"13","author":"Mant","year":"2009","journal-title":"Health Technol Assess (Rockv)"},{"key":"2026012114095824100_ehf214314-bib-0017","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","author":"Doust","year":"2004","journal-title":"Arch Intern Med"},{"key":"2026012114095824100_ehf214314-bib-0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10741-014-9445-8","article-title":"Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review","volume":"19","author":"Booth","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026012114095824100_ehf214314-bib-0019","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/eurheartj\/ehq163","article-title":"Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care","volume":"31","author":"Hildebrandt","year":"2010","journal-title":"Eur Heart J"},{"key":"2026012114095824100_ehf214314-bib-0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1445-5994.2007.01454.x","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald","year":"2008","journal-title":"Intern Med J"},{"key":"2026012114095824100_ehf214314-bib-0021","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejheart.2005.10.004","article-title":"Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review","volume":"8","author":"Latour-P\u00e9rez","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0022","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.15536.2","article-title":"Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis","volume":"4","author":"Goyder","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2026012114095824100_ehf214314-bib-0023","volume-title":"Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0","author":"Macaskill","year":"2010"},{"key":"2026012114095824100_ehf214314-bib-0024","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026012114095824100_ehf214314-bib-0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmjebm-2020-111650","article-title":"Extracting data from diagnostic test accuracy studies for meta-analysis","volume":"26","author":"Taylor","year":"2021","journal-title":"BMJ Evidence-Based Med"},{"key":"2026012114095824100_ehf214314-bib-0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"2026012114095824100_ehf214314-bib-0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2006.08.046","article-title":"Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"49","author":"Le Jemtel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0028","volume-title":"Review Manager (RevMan) Version 5.3","year":"2014"},{"key":"2026012114095824100_ehf214314-bib-0029","volume-title":"Diagmeta: meta-analysis of diagnostic accuracy studies with several cutpoints","author":"R\u00fccker","year":"2018"},{"key":"2026012114095824100_ehf214314-bib-0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-016-0196-1","article-title":"Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies","volume":"16","author":"Steinhauser","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"2026012114095824100_ehf214314-bib-0031","volume-title":"Stata statistical software: release 15","author":"StataCorp","year":"2017"},{"key":"2026012114095824100_ehf214314-bib-0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cardfail.2008.12.002","article-title":"The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study","volume":"15","author":"Betti","year":"2009","journal-title":"J Card Fail"},{"key":"2026012114095824100_ehf214314-bib-0033","first-page":"313","article-title":"Screening of asymptomatic left ventricular systolic dysfunction in a population sample at high cardiovascular risk in Lombardy (Italy): the DAVID-berg study","volume":"15","author":"Gavazzi","year":"2014","journal-title":"G Ital Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0034","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejheart.2007.10.003","article-title":"Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysis","volume":"9","author":"Goode","year":"2007","journal-title":"Eur J Hear Fail 2007"},{"key":"2026012114095824100_ehf214314-bib-0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/SMJ.0b013e3181e1ffec","article-title":"Handheld ultrasound, B-natriuretic peptide for screening stage B heart failure","volume":"103","author":"Hebert","year":"2010","journal-title":"South Med J"},{"key":"2026012114095824100_ehf214314-bib-0036","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aprim.2010.12.009","article-title":"Validity and usefulness of B-type natriuretic peptide (BNP) for early detection of left ventricular dysfunction in high-risk patients in primary care","volume":"44","author":"Lobos Bejarano","journal-title":"Aten Primaria"},{"key":"2026012114095824100_ehf214314-bib-0037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-009-0108-z","article-title":"Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction","volume":"99","author":"Luers","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0038","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/eurjhf\/hfs030","article-title":"Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction","volume":"14","author":"Murtagh","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0053560","article-title":"Utility of biomarkers in the differential diagnosis of heart failure in older people: findings from the heart failure in care homes (HFinCH) diagnostic accuracy study","volume":"8","author":"Mason","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012114095824100_ehf214314-bib-0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ahj.2006.05.007","article-title":"Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide","volume":"152","author":"Abhayaratna","year":"2006","journal-title":"Am Heart J"},{"key":"2026012114095824100_ehf214314-bib-0041","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bmj.320.7239.906","article-title":"Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study","volume":"320","author":"Smith","year":"2000","journal-title":"Br Med J"},{"key":"2026012114095824100_ehf214314-bib-0042","first-page":"1252","article-title":"Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study","volume":"2002","author":"Vasan","journal-title":"JAMA"},{"key":"2026012114095824100_ehf214314-bib-0043","first-page":"236","article-title":"Value of NTproBNP concentration in an out-of-hospital adult population","volume":"56","author":"Cosin Aguilar","journal-title":"Rev Esp Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0044","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2005.09.025","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction","volume":"47","author":"Costello-Boerrigter","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ahj.2008.12.017","article-title":"Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas heart study","volume":"157","author":"de Lemos","year":"2009","journal-title":"Am Heart J"},{"key":"2026012114095824100_ehf214314-bib-0046","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/eurheartj\/ehl406","article-title":"Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction","author":"Goetze","year":"2006","journal-title":"Eur Heart J"},{"key":"2026012114095824100_ehf214314-bib-0047","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"2026012114095824100_ehf214314-bib-0048","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ahj.2004.03.034","article-title":"Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women","volume":"148","author":"Hedberg","year":"2004","journal-title":"Am Heart J"},{"key":"2026012114095824100_ehf214314-bib-0049","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00004872-200018080-00018","article-title":"Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population","volume":"18","author":"Luchner","year":"2000","journal-title":"J Hypertens"},{"key":"2026012114095824100_ehf214314-bib-0050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1388-9842(03)00154-5","article-title":"Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography","volume":"5","author":"Ng","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0051","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/eurheartj\/ehi559","article-title":"What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?","volume":"27","author":"Galasko","year":"2005","journal-title":"Eur Heart J"},{"key":"2026012114095824100_ehf214314-bib-0052","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/hrt.2003.014258","article-title":"Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations","volume":"90","author":"Hobbs","year":"2004","journal-title":"Heart"},{"key":"2026012114095824100_ehf214314-bib-0053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"2026012114095824100_ehf214314-bib-0054","first-page":"1102","article-title":"Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from \u201cPREDICTOR\u201d, a population based-study in Central Italy","volume":"15","author":"Mureddu","year":"2014","journal-title":"Epidemiology"},{"key":"2026012114095824100_ehf214314-bib-0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejheart.2004.12.010","article-title":"BNP as a marker of diastolic dysfunction in the general population: importance of left ventricular hypertrophy","volume":"7","author":"Lukowicz","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0056","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ejhf.1996","article-title":"National trends in heart failure mortality in men and women, United Kingdom, 2000\u20132017","volume":"23","author":"Taylor","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0057","first-page":"548","article-title":"Natriuretic peptides in the detection of left ventricular dysfunction in a high risk population. A meta-analysis of diagnostic tests","volume":"27","author":"D\u00edaz","year":"2020","journal-title":"Rev Colomb Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0058","article-title":"Natriuretic peptides for heart failure screening in nursing homes: a systematic review","author":"Homar","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2026012114095824100_ehf214314-bib-0059","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/2047487317749897","article-title":"Efficient selective screening for heart failure in elderly men and women from the community: a diagnostic individual participant data meta-analysis","volume":"25","author":"Kievit","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026012114095824100_ehf214314-bib-0060","first-page":"881","article-title":"Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study","author":"Roalfe","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114095824100_ehf214314-bib-0061","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/ehf2.13834","article-title":"N-terminal pro brain natriuretic peptide reference values in community-dwelling older adults","volume":"9","author":"Braisch","year":"2022","journal-title":"ESC Hear Fail"},{"key":"2026012114095824100_ehf214314-bib-0062","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114095824100_ehf214314-bib-0063","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h910","article-title":"The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"key":"2026012114095824100_ehf214314-bib-0064","first-page":"291","article-title":"Systematic review and meta-analysis: diagnostic accuracy of faecal immuno-chemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population","volume":"82","author":"Stonestreet","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"2026012114095824100_ehf214314-bib-0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(16)30196-6","article-title":"Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis","volume":"4","author":"Nambi","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026012114095824100_ehf214314-bib-0066","doi-asserted-by":"crossref","first-page":"PA3781","DOI":"10.1183\/13993003.congress-2016.PA3781","volume-title":"12 Rehabilitation and Chronic Care","author":"James","year":"2016"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14314","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14314","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/3\/1643\/65017670\/eschf_10_3_1643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/3\/1643\/65017670\/eschf_10_3_1643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:10:59Z","timestamp":1769022659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/3\/1643\/8304668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,13]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14314","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"2021-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}